Recently diagnosed with HIV? Click here

CNS HAND

Clinical trial • Enrolling • 23 November 2011
This trial is enrolling now. Depending on eligibility and available places in your area, you may be able to enrol in this trial.

About this trial

The purpose of this study is to determine the prevalence of HIV Associated Neurological Disorder (HAND) amongst people with HIV in a clinicalPertaining to or founded on observation and treatment of participants, as distinguished from theoretical or basic science. care setting.

For this the investigators will be comparing the performance of a group of people living with HIV with a group who are HIV negative by testing everyone's memory and concentration abilities over time.

They will be utilising various screening methods to ascertain the optimal methods for assessing HAND.

Official title:The CNS HAND Study: The Prevalence of Neurocognitive Disorder in a Primary Care-based HIV Cohort Compared to a HIV-negative Control Cohort
What is this trial studying?Other
Start date:October 2011

This may be the proposed or expected start date for trials which have not yet started.

How many participants will this trial enrol?320

The exact number of participants may be lower or slightly higher than this. Some trials also have specific quotas for participants from each state, city or clinic.

How long is this trial planned to go for?Participants in this trial will be asked to follow the trial protocol for 2 years.
Links to further information:

Who can enrol in this trial?

You may be eligible to participate in this trial if you meet the following criteria:

  • At least 18 years old
  • HIV-positive
  • HIV negative participants also required

This is a summary of key inclusion and exclusion criteria for this trial. There may be other criteria which may exclude some people from participation in this trial. Some laboratory tests may also be required. Consult your doctor, or view the trial protocol or informed consent documentation to see the full range of exclusion and inclusion criteria.

If you are interested in enrolling in this trial

Before making the decision to participate in any clinical trial, NAPWA recommends that you discuss the potential benefits and risks of participation with your treating doctor. Your doctor can also provide advice about your eligibility to participate in the trial.

While NAPWA has taken every care to compile the information on this page and to keep it up-to-date, we cannot guarantee its correctness and completeness.

  • You can print this page to take it with you to the doctor – just use your browser's 'print' function.
  • Before making the decision to participate in any clinical research, read our background information.
  • Email NAPWA if you have any questions or comments about this trial
Text size: font smallerfont normalfont larger print-friendly version of this pagePDF version of this pageemail this page to a friend

This Clinical trial was first published on 23 November 2011.

While the content of this clinical trial was checked for accuracy at the time of publication, NAPWA recommends checking to determine whether the information is the most up-to-date available, especially when making decisions which may affect your health.

Website links

HIV Clinical Trials update

Recently updated entries from the NAPWA Clinical Trials database.

more